Download Free Medical About Pharmacokinetics PowerPoint Presentation

About Pharmacokinetics PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "PHARMACOKINETICS" by DR NARENDRA KUMAR.

This medical PowerPoint presentation is about pharmacokinetics, the study of the movement of drugs within the body, including their absorption, distribution, metabolism, and elimination (ADME). These processes determine the concentration and duration of drug action in the body.

The pharmacokinetic properties of a drug are influenced by several factors, including its chemical structure, route of administration, and patient-specific factors such as age, sex, and health status. Understanding pharmacokinetics is important in drug development and clinical practice, as it helps to determine the appropriate dosing regimen, potential drug interactions, and the likelihood of adverse effects.

Tags : pharmacokinetics, pharmaceuticals, pharmaceuticals PowerPoint presentations

Published on : Jun 23, 2023 | Views : 1769 | Downloads : 3

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

PHARMACOKINETICS DR NARENDRA KUMAR
Slide 2-

Pharmacokinetics of drugs (ADME) Are studies of Absorption Distribution Metabolism Excretion of drugs
Slide 3-

ppt slide no 3 content not found
Slide 4-

ppt slide no 4 content not found
Slide 5-

Importance of PK studies Patients may suffer: Toxic drugs may accumulate Useful drugs may have no benefit because doses are too small to establish therapy A drug can be rapidly metabolized.
Slide 6-

DRUG ABSORPTION Is the passage of drug through cell membranes to reach its site of action. Mechanisms of drug absorption Simple diffusion = passive diffusion. Active transport. Facilitated diffusion. Pinocytosis (Endocytosis).
Slide 7-

Cell membrane
Slide 8-

ppt slide no 8 content not found
Slide 9-

Simple or passive diffusion water soluble drug (ionized or polar) is readily absorbed via aqueous channels or pores in cell membrane. Lipid soluble drug (nonionized or non polar) is readily absorbed via cell membrane itself.
Slide 10-

ppt slide no 10 content not found
Slide 11-

ppt slide no 11 content not found
Slide 12-

Simple diffusion Characters common. Occurs along concentration gradient Non selective Not saturable Requires no energy No carrier is needed Depends on lipid solubility Depends on pka of drug - pH of medium
Slide 13-

ppt slide no 13 content not found
Slide 14-

ppt slide no 14 content not found
Slide 15-

ppt slide no 15 content not found
Slide 16-

PKa of the drug (Dissociation or ionization constant): pH at which half of the substance is ionized & half is unionized. pH of the medium Affects ionization of drugs. Weak acids  best absorbed in stomach. Weak bases  best absorbed in intestine.
Slide 17-

Active Transport Occurs against concentration gradient. Requires carrier and energy. Specific Saturable. Iron absorption. Uptake of levodopa by brain.
Slide 18-

ppt slide no 18 content not found
Slide 19-

ppt slide no 19 content not found
Slide 20-

ppt slide no 20 content not found
Slide 21-

Carrier-mediated Facilitated Diffusion Occurs along concentration gradient. Requires carriers Selective. Saturable. No energy is required.
Slide 22-

ppt slide no 22 content not found
Slide 23-

ppt slide no 23 content not found
Slide 24-

ppt slide no 24 content not found
Slide 25-

Endocytosis: uptake of membrane-bound particles. Exocytosis: expulsion of membrane-bound particles. High molecular weight drugs or Highly lipid insoluble drugs Phagocytosis (Endocytosis & Exocytosis)
Slide 26-

ppt slide no 26 content not found
Slide 27-

ppt slide no 27 content not found
Slide 28-

ppt slide no 28 content not found
Slide 29-

Factors Affecting Bioavailability Molecular weight of drug. Drug Formulation (ease of dissolution). (solution > suspension > capsule > tablet) Solubility of the drug Chemical instability in gastric pH (Penicillin & insulin ) First pass metabolism reduces bioavailability
Slide 30-

ppt slide no 30 content not found
Slide 31-

Factors Affecting Bioavailability (BAV) Intestinal motility (Transit Time) Diarrhea reduce absorption Drug interactions Food slow gastric emptying generally slow absorption Tetracycline, aspirin, penicillin V
Slide 32-

ppt slide no 32 content not found
Slide 33-

Drug Distribution • Once in the bloodstream, a drug is distributed throughout the body • Very little of the drug is in contact with receptors at any given time • Most of the drug is in areas remote from the site of action (of interest), such as – Plasma binding sites – Muscle tissue – Adipose tissue (fat) – Liver – Kidneys
Slide 34-

VOLUME OF DISTRIBUTION Apparent volume of distribution (V d) Presuming that the body behaves as a single homogeneous compartment with volume V into which drug gets immediately and uniformly distributed
Slide 35-

ppt slide no 35 content not found
Slide 36-

ppt slide no 36 content not found
Slide 37-

ppt slide no 37 content not found
Slide 38-

Metabolism Liver is the primary site for metaboloism. Most of the drugs are inactivated by metabolism. Some drugs may be activated from the inactive compunds (Prodrugs) and others may give rise to active metabolites from the active compound. Metabolism may occur with help of microsomal or non-microsomal enzymes. Microsomal enzymes (monooxygenase, cytochrome P450 and glucoronyl transferase) may be induced or inhibited by other drugs whereas non-microsomal enzymes are not subjected to these interactions.
Slide 39-

Enzyme inducers Increases the metabolism of other drugs and reduce their effect.
Slide 40-

Enzyme inhibitors
Slide 41-

Prodrug Few drugs are inactive as such and need conversion in the body to one or more active metabolites. Such a drug are called a prodrug . The prodrug may offer advantages over the active form in being more stable, having better bioavailability or other desirable pharmacokinetic properties or less side effects and toxicity. Some prodrugs are activated selectively at the site of action.
Slide 42-

Phases of Drug Metabolism Phase I (non-synthetic) – in this reaction functional group get attached with drug molecule. After phase I reaction, drug may become water soluble or lipid soluble. Phase II (synthetic) – in this reaction a conjugate is attached to drug and make it water soluble.
Slide 43-

Metabolic Reactions
Slide 44-

ppt slide no 44 content not found
Slide 45-

Excretion Kidney is the major route of excretion. Excretion through kidneys occurs by glomerular filtration, tubular reabsorption and tubular secretion. Glomerular filtration depend on the plasma protein binding and renal blood flow. It does not depend on the lipid solubility because all substances (wether water soluble or lipid soluble) can cross fenestrated glomerular membrane. Tubular reabsorption depends on lipid solubility. If a drug is lipid soluble, more of it will be reabsorbed and less will be excreted. Opposite is true for lipid insoluble drugs.
Slide 46-

Excretion As lipid solubility depends on ionization, the ionized drug will be excreted by the kidney. Thus, in acidic drug poisoning (salicylate, barbiturates etc.) urine should be alkalinized with sodium bicarbonate because weak acids are in ionized from in alkaline urine and thus are easily excreted. Similarly for basic drug poisoning (e.g. morphine, amphetamine etc.), urine should be acidified using ammonium-chloride.
Slide 47-

Excretion Tubular secretion Does not depend on lipid solubility or plasma protein binding. In the nephron, separate pumps are present for acidic and basic drugs. Drugs utilizing the same transporter may show drug interactions e.g. Probenecid decreases the excretion of penicillin and increases the excretion of uric acid. Remember, exogenous substances e.g. Penicillins are removed whereas endogenous substances like uric acid are retained by these pumps.
Slide 48-

Kinetics Of Elimination Rate of elimination is the amount of drug eliminated (in units of weight like grams) per unit time. If it is seen as a function of plasma concentration, we derive an important parameter known as clearance (CL). Thus clearance is the rate of elimination of a drug divided by its plasma concentration.
Slide 49-

ppt slide no 49 content not found
Slide 50-

ppt slide no 50 content not found
Slide 51-

The drugs whose kinetics changes from first order to zero order at therapeutic concentration are said to follow pseudo- zero order kinetics.
Slide 52-

Plasma half-life
Slide 53-

ppt slide no 53 content not found
Slide 54-

ppt slide no 54 content not found
Slide 55-

Dose strategy The drugs having high volume of distribution are given by this strategy. First a large dose (loading dose) is administered to attain the steady state quickly and later on, to maintain the plasma concentration smaller dose is given (maintenance dose). Loading dose : it is given to load (saturate) the tissue stores. So it is mainly dependent on V d . Loading dose = V d x Target plasma concentration
Slide 56-

Maintenance Dose It is mainly dependent on CL. Maintenance dose = CL x Target plasma conc.
Slide 57-

Therapeutic Drug Monitoring (TDM) TDM is a process by which the dose of a drug is adjusted according to its plasma concentration. It is done for drugs having wide variation in pharmacokinetics ,both intra- as well as inter- individual. It is done for the drugs having low therapeutic index like theophylline, lithium, antiepileptics, immuno-modulators and anti-arrhythmics etc. TDM is done for those whose effect cannot be easily measured (like effect of antihypertensive drugs can be easily measured by monitoring BP, so TDM is not used). TDM is not done for the drugs which are activated in the body or produce active metabolites (Prodrugs).
Slide 58-

Fixed dose ratio combination preparations Advantages Convenience and better patient compliance. 2. Certain drug combinations are synergistic, e.g. sulfamethoxazole + trimethoprim; levodopa + carbidopa/benserazide; combination oral contraceptives. 3. The therapeutic effect of two components being same may add up while the side effects being different may not, e.g. amlodipine + atenolol as antihypertensive. 4. The side effect of one component may be counteracted by the other, e.g. a thiazide + a potassium sparing diuretic. 5. Combined formulation ensures that a single drug will not be administered. This is important in the treatment of tuberculosis and HIV-AIDS.
Slide 59-

Disadvantages of fixed dose ratio combinations 1. The patient may not actually need all the drugs present in a combination 2. The dose of most drugs needs to be adjusted and individualised. When a combined formulation is used, this cannot be done without altering the dose of the other component(s). 3. The time course of action of the components may be different: administering them at the same intervals may be inappropriate. 4. Altered renal or hepatic function of the patient may differently affect the pharmacokinetics of the components. 5. Adverse effect, when it occurs, cannot be easily ascribed to the particular drug causing it. 6. Contraindication to one component (allergy, other conditions) contraindicates the whole preparation. Confusion of therapeutic aims and false sense of superiority of two drugs over one is fostered, specially in case of antimicrobials whose combinations should be avoided. Corticosteroids should never be combined with any other drug meant for internal use.
Slide 60-

Bibliography Essentials of Medical Pharmacology -7th edition by KD Tripathi Goodman & Gilman's the Pharmacological Basis of Therapeutics 12th edition by Laurence Brunton (Editor) Lippincott's Illustrated Reviews: Pharmacology - 6th edition by Richard A. Harvey Basic and Clinical pharmacology 11th edition by Bertram G Katzung Rang & Dale's Pharmacology -7th edition by Humphrey P. Rang Clinical Pharmacology 11th edition By Bennett and Brown, Churchill Livingstone Principles of Pharmacology 2nd edition by HL Sharma and KK Sharma Review of Pharmacology by Gobind Sparsh Internet web.